Long-term outcomes and durability of Inceptiv™ spinal cord stimulation therapy
Official title: Post Market Evaluation of Real World Outcomes and Durability to Support Implantable SCS Therapy (PERSIST) Addendum - Inceptiv™ Spinal Cord Stimulation (SCS) Therapy
Run by Medtronic · NCT07507422 · Data updated 2026-11-12
This project will try to see if the Inceptiv™ spinal cord stimulation system provides lasting pain relief for adults with chronic or intractable pain who are new to SCS.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 970 (estimated) |
| Sponsor | Medtronic Industry-sponsored |
| Locations | 10 sites (Phoenix, Arizona and 9 other locations) |
| Status | Recruiting |
| Started | April 17, 2026 |
| Main results expected | June 27, 2029 |
| Study ends | January 11, 2034 |
| Registry record updated | November 5, 2026 |
| Trial ID | NCT07507422 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) who are SCS‑naïve, have predominant pain intensity ≥6 on the NPRS, have an on‑label indication in their geography, and who proceed to implantation after a satisfactory SCS trial are ideal candidates.
✕Probably not a fit
Patients with prior SCS implants, pain below the entry threshold, off‑label indications, or major medical contraindications are unlikely to gain benefit from enrollment in this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PERSIST is an observational post-market registry within Medtronic's Product Surveillance Registry that will collect long-term, real-world outcomes after implantation of commercially available Inceptiv™ spinal cord stimulation systems. Adults who are SCS‑naïve and meet local on‑label indications who proceed to implantation after a satisfactory trial will be enrolled at participating U.S. centers. The registry will longitudinally capture pain scores, opioid use, device performance and durability, and adverse events to characterize real-world effectiveness and device longevity. No experimental procedures are added; treatment follows standard clinical care and data are collected over time.
Why it matters
Potential benefit: If successful, this could confirm durable pain relief and provide patients and clinicians with clearer information about long-term device performance and safety.
How similar studies have gone: Other spinal cord stimulation systems have demonstrated durable pain reductions in prior randomized and observational studies, so this registry aims to provide device‑specific long‑term real‑world confirmation rather than test a new concept.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria:
1. 18 years of age or older
2. Patient must be SCS therapy naïve
3. A clinical decision was made for the patient to receive an Inceptiv™ SCS system (pending satisfactory results from a Medtronic SCS trial) limited to on-label leads based on the specific geography for an on-label indication prior to enrollment in the study.
4. Patient is on stable opioid dosage for 3 months prior to enrollment, if applicable
5. Pain intensity of ≥ 6 as measured using the NPRS (0-10) in the predominant area(s) of pain that SCS is intended to treat
6. Patient must have an on-label indication specific to geography.
* NOTE: Patients may be enrolled if they have upper limb radicular limb pain, related or unrelated to spine surgery
* NOTE: In the US, patients experiencing chronic back pain without a history of spine surgery and not eligible for spine surgery are on-label candidates for SCS if the pain is associated with degenerative disc disease, herniated disc, or radicular pain syndrome. Radicular pain syndrome (with or without prior spine surgery) is an approved indication for SCS implant.
7. Diagnosis of chronic back and/or limb pain for an on-label indication lasting at least six months.
Exclusion Criteria:
1. Has any existing or is planning to have a new active implantable neuromodulation device or system during the 5 year follow up period (e.g., peripheral nerve stimulation, sacral neuromodulation, intrathecal drug delivery system, a second SCS system)
2. Has a complex pain pattern that involves both upper and lower limbs or back and upper limb
3. Has a planned major medical procedure within 6 months before enrollment or after implant that may interfere with study results or confound results as determined by the Investigator
4. Has a planned interventional procedure within 6 weeks (+/- 2 weeks) before enrollment or after implant that may interfere with study results or confound results as determined by the Investigator
5. Major untreated or unstable psychiatric comorbidity, such as suicidal ideations, personality disorders, schizophrenia etc., that could interfere with accurate pain reporting, study procedures, and/or confound evaluation of study, as determined by the Investigator
6. Subjects with PCS total score \>30 are not eligible unless ALL of the following are met:
1. Absence of uncontrolled major psychiatric disorder or active suicidality based on clinical evaluation.
2. Investigator documentation of adequate understanding of therapy, realistic expectations, and anticipated compliance with protocol follow-up
7. Major non-indicated, untreated or refractory progressive disease (e.g., neurodegenerative disease {not including Diabetic Peripheral Neuropathy}, heart failure, cancer, osteoarthritis, fibromyalgia, chronic fatigue syndrome), or injury (e.g., fall resulting in hip fracture) that could interfere with accurate pain reporting, study procedures, and/or confound evaluation of study as determined by the Investigator
8. Has inpatient or outpatient admissions for drug or alcohol dependency within past 12 months or current/ongoing substance abuse
9. Has a current prescription of ≥90 morphine milligram equivalents (MME) per day
10. Has predominant mechanical back pain arising from facet or sacroiliac joint pain as the main cause of chronic low-back pain if low-back pain is the predominant pain condition, as determined by the Investigator
11. Has mechanical spine instability (eg. Spondylolisthesis grade 2) as determined by the Investigator
12. Has an active systemic or local infection that would delay trial or implant
13. Is pregnant or planning on becoming pregnant
14. Has a life expectancy of less than 1 year
15. Involved in an injury claim, under current litigation, beneficiary of an injury claim, receiving worker's compensation, or planning any future litigation
16. Has a condition that the Investigator determines would significantly increase perioperative risk (e.g., unstable or severe cardiac disease, liver disease, uncontrolled diabetes, kidney disease)
Patients enrolled into the study with Diabetic Peripheral Neuropathy, Complex Regional Pain Syndrome and Upper Limb pain are required to meet further inclusion/exclusion criteria in order to contribute to the analysis for that particular condition. These criteria are designed to ensure that the patient's condition aligns with the standard diagnostic criteria set by applicable clinical guidelines.
Painful Diabetic Peripheral Neuropathy (DPN) Inclusion Criteria
* Clinical diagnosis of diabetes mellitus according to the American Diabetes Association guidelines (ADA).
* Predominant pain condition being treated by SCS is lower-limb pain due to DPN
* Hemoglobin A1c (HbA1c) must be \<8% within 6 months of enrollment for inclusion or have completed a preoperative risk assessment if \>8%
* Presence of either numbness or at least one sensory disturbance (e.g., increased or decreased sensitivity, burning, pricking/stabbing, aching, "pins and needle" sensation) in the foot/feet.
Painful DPN Exclusion Criteria
* Lower-limb pain not associated with DPN or that cannot be distinguished from DPN (e.g., mononeuropathies, proximal neuropathies, nonneuropathic pain, peripheral vascular disease)
* History of lower-limb amputation or planned lower-limb amputations due to diabetes
* Large (≥3cm) and/or gangrenous ulcers or active infection of the lower limbs
Complex Regional Pain Syndrome (CRPS) Inclusion Criteria
* Meets diagnostic criteria for CRPS (International Association for the Study of Pain "Budapest Criteria")
* Disease that is clinically restricted to one hand or foot and affects the entire hand, foot or lower extremity
* CRPS is the predominant pain condition that SCS is intended to treat
CRPS Exclusion Criteria
* Presence of Reynaud's disease
* Current or previous neurologic abnormalities unrelated to CRPS
* Another condition affecting the function of the diseased or contralateral extremity
* Dystonia as a predominant component of their presentation
Upper Limb Pain (ULP) - non CRPS Inclusion Criteria
* Be diagnosed with radicular pain syndrome, or be diagnosed with radicular pain secondary to failed back surgery or herniated disk
ULP - non CRPS Exclusion Criteria
* Has significant cervical stenosis, as determined by the Investigator
* Failed treatments of carpal tunnel syndrome and/or cubital tunnel syndrome
* Has mechanical neck pain (e.g., facet spondylosis), as determined by the Investigator
* Any previous history of surgery on the posterior elements (laminectomy, posterior fusion) of the cervical spine
* Has brachial plexus injury as predominant cause of pain
Where it's running
-
Center for Pain and Supportive Care
Phoenix, Arizona, United States Recruiting -
Relieve Pain Center
San Diego, California, United States Recruiting -
Innovative Pain Treatment Solutions
Temecula, California, United States Recruiting -
Christian Hospital
St Louis, Missouri, United States Recruiting -
5500 Reno Corporate Dr Ste 300
Reno, Nevada, United States Recruiting -
Pain Diagnostics and Interventional Care
Sewickley, Pennsylvania, United States Recruiting
Show 4 more locations
-
North Texas Orthopedics and Spine Center
Houston, Texas, United States Recruiting -
Christus Surgery Center- Westover Hills, LLC
San Antonio, Texas, United States Recruiting -
Hôpital Claude Huriez
Lille, France Recruiting -
Hopital de La Tour Clinique de la Douleur
Meyrin, Switzerland Recruiting
Study contacts
- Study coordinator: Study Inbox
- Email: rs.persiststudy@medtronic.com
- Phone: 1-800-633-8766
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Time‑variant pulse spinal cord stimulation for chronic low back and leg pain
This trial will test whether time‑variant pulse spinal cord stimulation using the Boston Scientific WaveWriter Alpha system can reduce chronic low back or leg pain in adults who have not found relief from other treatments.
-
Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work
This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.
-
One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital
A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.
-
Meaning-Based Psychotherapy for Adults with Chronic Pain
This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.
-
How chronic pain changes over time in kids with Duchenne Muscular Dystrophy
This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.
-
CBD for Opioid Dependence and Pain on Buprenorphine
This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.